Competitive, Meaningful Work
Feb 05, 2025•22 min
Episode description
Jonathan Violin, CEO of Crescent Biopharma and Venture Partner at Fairmount, speaks with Venrock partner Nimish Shah about how the company is keeping a frenetic and exciting pace to generate a new class of drugs while preparing to launch on the public markets later this year.
For the best experience, listen in Metacast app for iOS or Android
